Evidence map›Paper›PMID 40468400›Full record

ArticleActa neuropathologica communications2025

Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis.

Christian J Riedl, Daniel Bormann, Anja Steinmaurer, Anja Novak, Giulia Testa, Elena Poldlehner, Carmen Haider, Thomas Berger, Michael Mildner, Romana Höftberger and 2 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christian J RiedlDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.ORCID 0000-0002-3641-768X
Daniel BormannDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Anja SteinmaurerComprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, 1090, Austria.
Anja NovakDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Giulia TestaDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Elena PoldlehnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Carmen HaiderDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Thomas BergerComprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, 1090, Austria.
Michael MildnerDepartment of Dermatology, Medical University of Vienna, Vienna, 1090, Austria.
Romana HöftbergerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria.
Ferdinand SchweserBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, 14203, USA.
Simon HametnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, 1090, Austria. simon.hametner@meduniwien.ac.at.ORCID 0000-0002-5160-5208

Funding

Deep Gray Matter Iron and Disease Progression in Multiple SclerosisR01NS114227 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SCHWESER, FERDINAND · 2021 to 2024
$1.5M
National Institute Of Neurological Disorders And Stroke of the National Institutes of Health R01NS114227NINDS NIH HHS R01 NS114227
6 · The paper itself

Abstract

Changes in brain iron levels are a consistent feature of multiple sclerosis (MS) over its disease course. They encompass iron loss in oligodendrocytes in myelinated brain regions and iron accumulation in myeloid cells at so-called paramagnetic rims of chronic active lesions. Here, we explore the mechanisms behind this overall shift of iron from oligodendrocytes (OLs) to myeloid cells (MCs) and the loss of total brain-iron in MS. We investigated the expression of various iron importers and exporters, applying immunohistochemistry to a sample of control and MS autopsy cases. Additionally, we studied the transcriptional response of iron-related genes in primary rodent OL progenitor cells (OPCs) and microglia (MG) to various combinations of known MS-relevant pro-inflammatory stimuli together with iron loading. Histologically, we identified a correlation of OL-iron accumulation and the expression of the ferritin receptor TIM1 in myelinated white matter and observed an increase in the expression of iron-related proteins in myeloid cells at the lesion rims of MS plaques. qPCR revealed a marked increase of the heme scavenging and degradation machinery of MG under IFN-γ exposure, while OPCs changed to a more iron-inert phenotype with apparent decreased iron handling capabilities under MS-like inflammatory stimulation. Collectively, our data suggest that OL iron loss in MS is mainly due to a decrease in ferritin iron import. Iron accumulation in MCs at rims of chronic active lesions is in part driven by up-regulation of heme import and metabolism, while these cells also actively export ferritin.

Indexed as

InflammationIronMultiple SclerosisMyeloid CellsOligodendrogliaAdultAgedAnimalsBrainFemaleHumansMaleMicrogliaMiddle AgedWhite MatterIronIron lossIron rim lesionsMicrogliaMultiple sclerosisOligodendrocytes

Identifiers

PMID40468400
PMCPMC12135419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.